High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma.

Authors:
Oliver M Fisher
Oliver M Fisher
St. Vincent's Centre for Applied Medical Research
Sarah J Lord
Sarah J Lord
University of Sydney
Australia
Natalia K Botelho
Natalia K Botelho
Garvan Institute of Medical Research
Australia
Melissa L Thomas
Melissa L Thomas
The University of Western Australia
Australia
Dan Falkenback
Dan Falkenback
Lund University Hospital
Sweden

Ann Surg Oncol 2015 Jul 28;22(7):2431-8. Epub 2014 Oct 28.

St. Vincent's Centre for Applied Medical Research, Sydney, Australia.

Background: Cathepsin E (CTSE), an aspartic proteinase, is differentially expressed in the metaplasia-dysplasia-neoplasia sequence of gastric and colon cancer. We evaluated CTSE in Barrett's esophagus (BE) and cancer because increased CTSE levels are linked to improved survival in several cancers, and other cathepsins are up-regulated in BE and esophageal adenocarcinoma (EAC).

Methods: A total of 273 pretreatment tissues from 199 patients were analyzed [31 normal squamous esophagus (NE), 29 BE intestinal metaplasia, 31 BE with dysplasia (BE/D), 108 EAC]. CTSE relative mRNA expression was measured by real-time polymerase chain reaction, and protein expression was measured by immunohistochemistry. CTSE serum levels were determined by enzyme-linked immunosorbent assay.

Results: Median CTSE mRNA expression levels were ≥1,000-fold higher in BE/intestinal metaplasia and BE/D compared to NE. CTSE levels were significantly lower in EAC compared to BE/intestinal metaplasia and BE/D, but significantly higher than NE levels. A similar expression pattern was present in immunohistochemistry, with absent staining in NE, intense staining in intestinal metaplasia and dysplasia, and less intense EAC staining. CTSE serum analysis did not discriminate patient groups. In a uni- and multivariable Cox proportional hazards model, CTSE expression was not significantly associated with survival in patients with EAC, although CTSE expression above the 25th percentile was associated with a 41 % relative risk reduction for death (hazard ratio 0.59, 95 % confidence interval 0.27-1.26, p = 0.17).

Conclusions: CTSE mRNA expression is up-regulated more than any known gene in Barrett intestinal metaplasia and dysplasia tissues. Protein expression is similarly highly intense in intestinal metaplasia and dysplasia tissues.

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-014-4155-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458267PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
July 2015
183 Reads

Publication Analysis

Top Keywords

metaplasia dysplasia
16
intestinal metaplasia
16
mrna expression
12
ctse
11
be/intestinal metaplasia
8
metaplasia be/d
8
barrett's esophagus
8
ctse levels
8
ctse mrna
8
ctse serum
8
dysplasia tissues
8
expression
8
ctse expression
8
protein expression
8
expression measured
8
metaplasia
6
levels
5
levels ≥1000-fold
4
≥1000-fold higher
4
higher be/intestinal
4

References

(Supplied by CrossRef)
Article in J Gastroenterol Hepatol.
WA Phillips et al.
J Gastroenterol Hepatol. 2011
Article in Cancer
C Eheman et al.
Cancer 2012
Article in Gastroenterology.
GS Dulai et al.
Gastroenterology. 2002
Article in Nature clinical practice. Gastroenterol Hepatol.
SJ Spechler et al.
Nature clinical practice. Gastroenterol Hepatol. 2007
Article in Hum Pathol.
BJ Reid et al.
Hum Pathol. 1988
Article in Gut.
RC Fitzgerald et al.
Gut. 2014
Article in Gastroenterology.
S Varghese et al.
Gastroenterology. 2012
Article in Cell Tissue Res.
Y Yoshimine et al.
Cell Tissue Res. 1995
Article in J Biochem
T Kageyama et al.
J Biochem 1980
Article in Biochim Biophys Acta.
K Yamamoto et al.
Biochim Biophys Acta. 2012
Article in Gut.
T Saku et al.
Gut. 1990

Similar Publications